EXDL1 Activators
EXDL1 Activators are a class of compounds that would directly or indirectly lead to the increased functional activity of the protein EXDL1. These activators work by influencing specific cellular signaling pathways or biological processes that EXDL1 is directly involved in. For example, the elevation of intracellular cAMP levels through the use of Forskolin or IBMX can activate protein kinase A (PKA), which may phosphorylate and activate EXDL1 if it is a substrate of PKA or involved in PKA-regulated pathways. Similarly, polyphenols like Epigallocatechin gallate and Curcumin can modulate various signaling molecules and pathways, leading to the cascading activation of EXDL1. These compounds can trigger cellular stress responses or modulate transcription factors and kinases, which could logically result in the activation of EXDL1 based on its involvement in these pathways.
Other compounds, such as Resveratrol and Metformin, act on metabolic control mechanisms, influencing sirtuins and AMPK respectively. If EXDL1is involved in pathways that are regulated by sirtuins or AMPK, then the activation of these proteins by Resveratrol and Metformin could also lead to the activation of EXDL1. This could occur through changes in gene expression, alterations in protein-protein interactions, or modifications of EXDL1's activity state due to phosphorylation or other post-translational modifications.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels. Elevated cAMP can enhance protein kinase A (PKA) activity, which can phosphorylate and activate proteins in pathways where EXDL1 is involved, leading to its functional activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-selective inhibitor of phosphodiesterases, preventing cAMP degradation. This leads to increased cAMP in the cell, which can upregulate PKA activity, indirectly enhancing the activation of EXDL1 by promoting phosphorylation events. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A polyphenol that influences multiple signaling pathways, including those involved in cellular stress responses. It can activate pathways that involve EXDL1, leading to its enhanced functional activity due to its role in these responses. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates various signaling molecules, including kinases and transcription factors, which can indirectly activate EXDL1 by initiating a cascade of signaling events that result in its functional activation within cellular pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Sirtuin activator that influences cellular metabolism. By activating sirtuins, it can enhance the functional activity of EXDL1 if EXDL1 is part of the metabolic control mechanisms regulated by sirtuins. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that by inhibiting the MEK-ERK pathway, can cause compensatory regulatory effects in other signaling pathways, potentially enhancing the functional activity of EXDL1 if it is regulated through alternative signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can modulate the AKT signaling pathway. Inhibition of PI3K can lead to alterations in downstream signaling, which may enhance the activation of EXDL1 by affecting related signaling proteins or pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, which can influence cellular stress response pathways. If EXDL1 functions as part of these pathways, inhibition of p38 MAPK could lead to alternative pathway activation and enhance the functional activity of EXDL1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can activate autophagy. If EXDL1 is involved in the autophagic pathway, inhibition of mTOR could enhance the activation of EXDL1 through the induction of autophagy-related signaling events. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Activates AMPK, which is a key regulator of energy homeostasis. Activation of AMPK can lead to changes in metabolic pathways that could enhance the functional activity of EXDL1 if it is implicated in these pathways. | ||||||